Loading...

DXCM DEXCOM INC Management Changes 8-K Filing

DXCM

DXCM

DEXCOM INC

(DXCM)

2026 8-K

Investor Day Highlights

Financial Results

Leadership Update

Board Appointment

Financial Results Announced

Financial Update

CEO Appointment

Financial Results Update

Board Appointment Update

Leadership Change

Equity Offerings

Board Appointment

FDA Warning Letter

Financial Results

Financial Results

Patent Settlement

Financial Results

Financial Results and Share...

Annual Meeting of Stockholders

Financial Results Announcement

Termination of Warrants

Financial Results Announcement

Preliminary Financial Results

Share Repurchase Agreement

Financial Results Announcement

Share Repurchase Program

Earnings Reports

Regulation FD Disclosure

Severance Plan Amendments

Sale of Convertible Senior ...

Earnings Reports

Financial Results Announcement

Financial Results

External Links:

DexCom Inc. reports that CEO Kevin Sayer will return from a leave of absence on March 2, 2026, after notifying the company on February 27, 2026. He has a new agreement with an annual salary of $610,000 and stock units worth $2,350,000, vesting in 2027.

AI Assistant

DEXCOM INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.